PMID- 19474282 OWN - NLM STAT- MEDLINE DCOM- 20091202 LR - 20220316 IS - 1460-2385 (Electronic) IS - 0931-0509 (Linking) VI - 24 IP - 10 DP - 2009 Oct TI - Alpha-lipoic acid attenuates cisplatin-induced acute kidney injury in mice by suppressing renal inflammation. PG - 3012-20 LID - 10.1093/ndt/gfp242 [doi] AB - BACKGROUND: Cisplatin is a chemotherapeutic agent used in treatment of malignant tumours. However, cisplatin produces various side effects, such as nephrotoxicity, neurotoxicity, emetogenesis and ototoxicity. Inflammation is an important mechanism of cisplatin nephrotoxicity. Alpha-lipoic acid (alpha-LA) has anti-inflammatory effects that inhibit both adhesion molecule expression in human endothelial cells and monocyte adhesion by suppressing the nuclear factor-kappaB (NF-kappaB) signalling pathway. The goals of this study were to investigate the anti-inflammatory effects of alpha-LA during cisplatin-induced renal injury and to examine the mechanisms of protection. METHODS: C57BL/6 mice were given cisplatin (20 mg/kg) with or without alpha-LA treatment (100 mg/kg for 3 days). Renal function, histological changes, adhesion molecule expression and inflammatory cell infiltration were examined. The effect of alpha-LA on NF-kappaB activity was evaluated by examining nuclear translocation and phosphorylation of NF-kappaB p65 subunits in kidney tissue. RESULTS: Cisplatin-induced decreases in renal function, measured by blood urea nitrogen, serum creatinine level and renal tubular injury scores, were attenuated by alpha-LA treatment. alpha-LA decreased the tissue levels of tumour necrosis factor-alpha, the expression of intercellular adhesion molecule-1 (ICAM-1) and monocyte chemoattractant protein-1 (MCP-1), and suppressed the infiltration of CD11b-positive macrophages. alpha-LA also attenuated the cisplatin-induced increases in the phosphorylation and nuclear translocation of NF- kappaB p65 subunits in kidney tissue. CONCLUSIONS: These results suggest that alpha-LA treatment ameliorates cisplatin-induced acute kidney injury by reducing inflammatory adhesion molecule expression and NF-kappaB activity. FAU - Kang, Kyung Pyo AU - Kang KP AD - Department of Internal Medicine and Renal Regeneration Laboratory, Chonbuk National University Medical School, Jeonju, Republic of Korea. FAU - Kim, Duk Hoon AU - Kim DH FAU - Jung, Yu Jin AU - Jung YJ FAU - Lee, Ae Sin AU - Lee AS FAU - Lee, Sik AU - Lee S FAU - Lee, Sang Yong AU - Lee SY FAU - Jang, Kyu Yun AU - Jang KY FAU - Sung, Mi Jeong AU - Sung MJ FAU - Park, Sung Kwang AU - Park SK FAU - Kim, Won AU - Kim W LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090527 PL - England TA - Nephrol Dial Transplant JT - Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association JID - 8706402 RN - 0 (Antineoplastic Agents) RN - 73Y7P0K73Y (Thioctic Acid) RN - Q20Q21Q62J (Cisplatin) SB - IM MH - Acute Kidney Injury/*chemically induced/*prevention & control MH - Animals MH - Antineoplastic Agents/*adverse effects MH - Cisplatin/*adverse effects MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Nephritis/*chemically induced/*prevention & control MH - Thioctic Acid/*therapeutic use EDAT- 2009/05/29 09:00 MHDA- 2009/12/16 06:00 CRDT- 2009/05/29 09:00 PHST- 2009/05/29 09:00 [entrez] PHST- 2009/05/29 09:00 [pubmed] PHST- 2009/12/16 06:00 [medline] AID - gfp242 [pii] AID - 10.1093/ndt/gfp242 [doi] PST - ppublish SO - Nephrol Dial Transplant. 2009 Oct;24(10):3012-20. doi: 10.1093/ndt/gfp242. Epub 2009 May 27.